Pravin Dugel Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Pravin Dugel is Director of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 833,353 shares of OCUL, which is worth approximately $5.47 Million. The most recent transaction as insider was on May 23, 2024, when has been sold 21,626 shares (Common Stock) at a price of $5.79 per share, resulting in proceeds of $125,214. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 833K
2.53% 3M change
n/a 12M change
Total Value Held $5.47 Million

Pravin Dugel Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
SELL
Open market or private sale
$125,214 $5.79 p/Share
21,626 Reduced 2.53%
833,353 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
854,979 Added 50.0%
854,979 Common Stock

Also insider at

ISEE
IVERIC bio, Inc. Healthcare
President
AADI
Aadi Bioscience, Inc. Healthcare
Director
PD

Pravin Dugel

Director
Parsippany, NJ

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL